RMTI Stock Analysis: Buy, Sell, or Hold?
RMTI - Rockwell Medical, Inc. (DE) Common Stock
$0.85
-0.02 (-2.30%)
▼
5d:
-16.65%
30d:
-5.6%
90d:
-1.67%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 11, 2026
Smart Money Accumulation
RMTI is down 12.6% this week, but smart money is accumulating calls. Top strike: $1.5 2026-05-15 with 241 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When RMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: RMTI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: RMTI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: RMTI is currently trading at $0.85, which is considered slightly low relative to its 30-day fair value range of $0.89 to $1.02.
Technical Outlook: Technically, RMTI is in a uptrend. The price is currently testing key support at $0.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RMTI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+282.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, RMTI is in a uptrend. The price is currently testing key support at $0.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: RMTI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.25 (+282.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$0.89 -
$1.02
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 282.3% below Wall St target ($3.25)
- CAUTION: 5-day price weakness (-16.6%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.89 -
$1.02
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.85
Resistance Level
$1.09
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.17
Wall Street Target
$3.25
(+282.3%)
Revenue Growth (YoY)
-25.6%
Profit Margin
-7.7%
Share & Embed Analysis
Last updated: March 30, 2026 10:19 PM ET
Data refreshes hourly during market hours. Next update: 11:19 PM
Data refreshes hourly during market hours. Next update: 11:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
John G Cooper
SELL
5079 shares
2025-11-18
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$178 | 63 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 55 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 63 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 56 HOLD |
